Selective Progesterone Receptor Modulator Development and Use in the Treatment of Leiomyomata and Endometriosis
The DOI matches its Crossref record; 122 of the 127 references it cites were found in a registry or an index.
Abstract
Selective progesterone receptor modulators (SPRMs) represent a new class of progesterone receptor ligands. SPRMs exert clinically relevant tissue-selective progesterone agonist, antagonist, or mixed agonist/antagonist effects on various progesterone target tissues in vivo. Asoprisnil (J867) is the first SPRM to reach an advanced stage of clinical development for the treatment of symptomatic uterine fibroids and endometriosis. Asoprisnil belongs to the class of 11beta-benzaldoxime-substituted estratrienes that exhibit partial progesterone agonist/antagonist effects with high progesterone receptor specificity in animals and humans. Asoprisnil has no antiglucocorticoid activity in humans at therapeutic doses. It exhibits endometrial antiproliferative effects on the endometrium and breast in primates. Unlike progesterone antagonists, asoprisnil does not induce labor in relevant models of pregnancy and parturition. It induces amenorrhea primarily by targeting the endometrium. In human subjects with uterine fibroids, asoprisnil suppressed both the duration and intensity of uterine bleeding in a dose-dependent manner and reduced tumor volume in the absence of estrogen deprivation. In subjects with endometriosis, asoprisnil was effective in reducing nonmenstrual pain and dysmenorrhea. Asoprisnil may, therefore, provide a novel, tissue-selective approach to control endometriosis-related pain. SPRMs have the potential to become a novel treatment of uterine fibroids and endometriosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Therefore, a potential good efficacy of SPRMs on endometriosis was suggested [260–262], but no SPRMs are used in clinical practice.”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [260]
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439
Giudice, L. C., & Kao, L. C. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17403-5 · Cited by 3,166
Breast cancer and hormone-replacement therapy in the Million Women Study
(2003) · The Lancet · doi:10.1016/s0140-6736(03)14065-2 · Cited by 2,993
MOLECULAR MECHANISMS OF ACTION OF STEROID/THYROID RECEPTOR SUPERFAMILY MEMBERS
Tsai, M.-J., & O'Malley, B. W. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.002315 · Cited by 2,932
High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence
Day Baird, D., Dunson, D. B., Hill, M. C., Cousins, D., & Schectman, J. M. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2003.99 · Cited by 2,435
Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily
Oñate, S. A., Tsai, S. Y., Tsai, M.-J., & O'Malley, B. W. (1995) · Science · doi:10.1126/science.270.5240.1354 · Cited by 2,387
Steroid Receptor Interactions with Heat Shock Protein and Immunophilin Chaperones*
Pratt, W. B., & Toft, D. O. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0303 · Cited by 1,791
A transcriptional co-repressor that interacts with nuclear hormone receptors
Chen, J. D., & Evans, R. M. (1995) · Nature · doi:10.1038/377454a0 · Cited by 1,763
Breast cancer and hormone-replacement therapy: the Million Women Study
Beral, V., Banks, E., Reeves, G., & Bull, D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14596-5 · Cited by 1,273
Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast Cancer
Love, R. R., Mazess, R. B., Barden, H. S., Epstein, S., Newcomb, P. A., Jordan, V. C., Carbone, P. P., & DeMets, D. L. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261302 · Cited by 1,129
Nuclear receptor coactivators and corepressors
Horwitz, K. B. (1996) · Molecular Endocrinology · doi:10.1210/me.10.10.1167 · Cited by 942
Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators
Smith, C. L., & O’Malley, B. W. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0023 · Cited by 931
Variation in the Incidence of Uterine Leiomyoma Among Premenopausal Women by Age and Race
Marshall, L. (1997) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(97)00534-6 · Cited by 889
Vegeto, E., Shahbaz, M. M., Wen, D. X., Goldman, M. E., O'Malley, B. W., & McDonnell, D. P. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.10.8264658 · Cited by 760
Hysterectomy in the United States, 1988-1990
WILCOX, L. S., KOONIN, L. M., POKRAS, R., STRAUSS, L. T., XIA, Z., & PETERSON, H. B. (1994) · Obstetrics & Gynecology · doi:10.1097/00006250-199404000-00011 · Cited by 664
Smith, C. S., Nawaz, Z., & O’Malley, B. W. (1997) · Molecular Endocrinology · doi:10.1210/me.11.6.657 · Cited by 662
Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation
McInerney, E. M., Rose, D. W., Flynn, S. E., Westin, S., Mullen, T.-M., Krones, A., Inostroza, J., Torchia, J., Nolte, R. T., Assa-Munt, N., et al. (1998) · Genes & Development · doi:10.1101/gad.12.21.3357 · Cited by 613
Differential Gene Regulation by the Two Progesterone Receptor Isoforms in Human Breast Cancer Cells
Richer, J. K., Jacobsen, B. M., Manning, N. G., Abel, M. G., Horwitz, K. B., & Wolf, D. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110090200 · Cited by 572
Jackson, T. A., Richer, J. K., Bain, D. L., Takimoto, G. S., Tung, L. W., & Horwitz, K. B. (1997) · Molecular Endocrinology · doi:10.1210/me.11.6.693 · Cited by 478
Jordan, V. C. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020449y · Cited by 414
Vegeto, E., Allan, G. F., Schrader, W. T., Tsai, M.-J., McDonnell, D. P., & O'Malley, B. W. (1992) · Cell · doi:10.1016/0092-8674(92)90234-4 · Cited by 377
Pharmacological profile of progestins
Sitruk-Ware, R. (2004) · Maturitas · doi:10.1016/j.maturitas.2004.01.001 · Cited by 374
Allan, G. F., Leng, X., Tsai, S. Y., Weigel, N. L., Edwards, D. P., Tsai, M. J., & O'Malley, B. W. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41805-4 · Cited by 355
Olive, D. L., & Pritts, E. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107263450407 · Cited by 340
Giangrande, P. H., & McDonnell, D. P. (1999) · PubMed · Cited by 339
Hofseth, L. J., Raafat, A. M., Osuch, J. R., Pathak, D. R., Slomski, C. A., & Haslam, S. Z. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.12.6194 · Cited by 329
Nuclear-Receptor Ligands and Ligand-Binding Domains
Weatherman, R. V., Fletterick, R. J., & Scanlan, T. S. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.559 · Cited by 322
Csapo, A. (1956) · American Journal of Anatomy · doi:10.1002/aja.1000980206 · Cited by 317
Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis
Ota, H., Igarashi, S., Sasaki, M., & Tanaka, T. (2001) · Human Reproduction · doi:10.1093/humrep/16.3.561 · Cited by 302
The Molecular Pharmacology of SERMs
McDonnell, D. P. (1999) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(99)00177-0 · Cited by 299
Reproductive tissue selective actions of progesterone receptors
Mulac-Jericevic, B., & Conneely, O. M. (2004) · Reproduction · doi:10.1530/rep.1.00189 · Cited by 276
Steroid receptor induction of gene transcription: A two-step model
Jenster, G., Spencer, T. E., Burcin, M. M., Tsai, S. Y., Tsai, M.-J., & O’Malley, B. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.7879 · Cited by 264
Wagner, B. L., Norris, J. D., Knotts, T. A., Weigel, N. L., & McDonnell, D. P. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.3.1369 · Cited by 255
Mote, P. A., Bartow, S., Tran, N., & Clarke, C. L. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1014820500738 · Cited by 255
McPhail, M. K. (1934) · The Journal of Physiology · doi:10.1113/jphysiol.1934.sp003217 · Cited by 245
Mitotic activity in uterine leiomyomas during the menstrual cycle
Kawaguchi, K., Fujii, S., Konishi, I., Nanbu, Y., Nonogaki, H., & Mori, T. (1989) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(89)80046-8 · Cited by 240
HORWITZ, K. B., & ALEXANDER, P. S. (1983) · Endocrinology · doi:10.1210/endo-113-6-2195 · Cited by 232
Brandon, D. D., Bethea, C. L., Strawn, E. Y., Novy, M. J., Burry, K. A., Harrington, M. S., Erickson, T. E., Warner, C., Keenan, E. J., & Clinton, G. M. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(93)90135-6 · Cited by 207
Kraus, W. L., McInerney, E. M., & Katzenellenbogen, B. S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12314 · Cited by 203
Carr, B. R. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.5.1217 · Cited by 184
New steroids with antiprogestational and antiglucocorticoid activities
Neef, G., Beier, S., Elger, W., Henderson, D., & Wiechert, R. (1984) · Steroids · doi:10.1016/s0039-128x(84)80027-6 · Cited by 183
Self-citationRegeneration in the Primate Uterus: The Role of Stem Cells
PADYKULA, H. A. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb37849.x · Cited by 181
Low-dose mifepristone for uterine leiomyomata
Eisinger, S. (2003) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(02)02511-5 · Cited by 181
Edwards, D. P. (2000) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1009503029176 · Cited by 180
Expanding functional diversity of the coactivators
Lonard, D. M., & O'Malley, B. W. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.01.001 · Cited by 172
Endometriosis—A disease because it is characterized by bleeding
Brosens, I. A. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70482-4 · Cited by 169
Regression of uterine leiomyomata to the antiprogesterone RU486: dose-response effect
Murphy, A. A., Morales, A. J., Michael Kettel, L., & Yen, S. S. C. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57678-x · Cited by 164
Progesterone Receptors in Mammary Gland Development and Tumorigenesis
Conneely, O. M., Mulac‐Jeričević, B., & Lydon, J. P. (2003) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1025952924864 · Cited by 161
Nisolle, M., Gillerot, S., Casanas-Roux, F., Squifflet, J., Berliere, M., & Donnez, J. (1999) · Human Reproduction · doi:10.1093/humrep/14.11.2844 · Cited by 159
RU 38486: An Original Multifaceted Antihormone in Vivo
(1984) · Adrenal Steroid Antagonism · doi:10.1515/9783110809572-004 · Cited by 159
Mammographic breast density during hormone replacement therapy: Differences according to treatment
Lundström, E., Wilczek, B., von Palffy, Z., Söderqvist, G., & von Schoultz, B. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70560-0 · Cited by 159
Englund, K., Blanck, A., Gustavsson, I., Lundkvist, U., Sjöblom, P., Norgren, A., & Lindblom, B. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.11.5287 · Cited by 155
Increased Expression of Cyclooxygenase‐2 in Local Lesions of Endometriosis Patients
CHISHIMA, F., HAYAKAWA, S., SUGITA, K., KINUKAWA, N., ALEEMUZZAMAN, S., NEMOTO, N., YAMAMOTO, T., & HONDA, M. (2002) · American Journal of Reproductive Immunology · doi:10.1034/j.1600-0897.2002.01101.x · Cited by 152
Jacobsen, B. M., Schittone, S. A., Richer, J. K., & Horwitz, K. B. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0287 · Cited by 146
Progesterone antagonists and progesterone receptor modulators: an overview
Spitz, I. M. (2003) · Steroids · doi:10.1016/j.steroids.2003.08.007 · Cited by 145
Mechanism of Action of Progesterone Antagonists
Leonhardt, S. A., & Edwards, D. P. (2002) · Experimental Biology and Medicine · doi:10.1177/153537020222701104 · Cited by 144
Effects of progesterone on uterine leiomyoma growth and apoptosis
Maruo, T. (2000) · Steroids · doi:10.1016/s0039-128x(00)00171-9 · Cited by 144
Matsuo, H., Maruo, T., & Samoto, T. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.1.3650 · Cited by 141
The use of progesterone antagonists for cervical ripening and as an adjunct to labour and delivery
Chwalisz, K. (1994) · Human Reproduction · doi:10.1093/humrep/9.suppl_1.131 · Cited by 137
Management of uterine leiomyomata: what do we really know?,
Myers, E. R., Barber, M. D., Gustilo-Ashby, T., Couchman, G., Matchar, D. B., & McCrory, D. C. (2002) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(02)02019-7 · Cited by 136
The Effect of Progestins on the Mitotic Activity of Uterine Fibromyomas
Tiltman, A. J. (1985) · International Journal of Gynecological Pathology · doi:10.1097/00004347-198506000-00001 · Cited by 134
Evaluation and management of women with endometriosis
Winkel, C. (2003) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(03)00474-5 · Cited by 131
Self-citationWu, M.-H. (2002) · Molecular Human Reproduction · doi:10.1093/molehr/8.12.1103 · Cited by 130
Pharmacological properties of mifepristone: toxicology and safety in animal and human studies
Sitruk-Ware, R. L., & Spitz, I. M. (2003) · Contraception · doi:10.1016/s0010-7824(03)00171-9 · Cited by 127
Reinsch, R. C., Murphy, A. A., Morales, A. J., & Yen, S. S. C. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(94)70332-9 · Cited by 123
Friedman, A. J., Daly, M., Juneau-Norcross, M., Rein, M. S., Fine, C., Gleason, R., & Leboff, M. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.6.8501148 · Cited by 121
Ismail, P. M., Amato, P., Soyal, S. M., DeMayo, F. J., Conneely, O. M., O’Malley, B. W., & Lydon, J. P. (2003) · Steroids · doi:10.1016/s0039-128x(03)00133-8 · Cited by 121
Chwalisż, K., Brenner, R. M., Fuhrmann, U. U., Hess-Stumpp, H., & Elger, W. (2000) · Steroids · doi:10.1016/s0039-128x(00)00190-2 · Cited by 113
Asoprisnil (J867): a selective progesterone receptor modulator for gynecological therapy
DeManno, D. A., Elger, W. A. G., Garg, R. C., Lee, R., Schneider, B., Hess‐Stumpp, H., Schubert, G., & Chwalisż, K. (2003) · Steroids · doi:10.1016/j.steroids.2003.09.008 · Cited by 111
Self-citationEffect of long-term treatment with low-dose mifepristone on the endometrium
Baird, D. T., Brown, A., Critchley, H. O. D., Williams, A. R., Lin, S., & Cheng, L. (2003) · Human Reproduction · doi:10.1093/humrep/deg022 · Cited by 111
Bagchi, M. K., Tsai, S. Y., Tsai, M., & O’Malley, B. W. (1990) · Nature · doi:10.1038/345547a0 · Cited by 109
Elger, W. A. G. (2000) · Steroids · doi:10.1016/s0039-128x(00)00178-1 · Cited by 109
Self-citationAllan, G. F., Tsai, S. Y., Tsai, M. J., & O'Malley, B. W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.11750 · Cited by 106
Studies on the mechanisms of action of progesterone antagonists
Elger, W. A. G., Beier, S., Chwalisż, K., Fähnrich, M., Hasan, S. H., Henderson, D. A., Neef, G., & Rohde, R. (1986) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(86)90314-6 · Cited by 105
Self-citationEnglund, K. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.11.4092 · Cited by 104
Sartorius, C. A., Shen, T., & Horwitz, K. B. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1024031731269 · Cited by 101
Williams, A. J., Powell, W. L., Collins, T., & Morton, C. C. (1997) · Europe PMC (PubMed Central) · Cited by 99
Matsuo, H. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.1.293 · Cited by 98
Steroid receptors and proliferation in the human breast
Clarke, R. B. (2003) · Steroids · doi:10.1016/s0039-128x(03)00122-3 · Cited by 96
Kim, J. J., Wang, J., Bambra, C. S., Das, S. K., Dey, S. K., & Fazleabas, A. T. (1999) · Endocrinology · doi:10.1210/endo.140.6.6716 · Cited by 85
Matsuo, H., Kurachi, O., Shimomura, Y., Samoto, T., & Maruo, T. (1999) · Oncology · doi:10.1159/000055275 · Cited by 83
Harrison-Woolrych, M. L. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.5.1179 · Cited by 79
Tumor Necrosis Factor- Expression in Human Uterine Leiomyoma and Its Down-Regulation by Progesterone
Kurachi, O., Matsuo, H., Samoto, T., & Maruo, T. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7469 · Cited by 78
Selective Progesterone Receptor Modulators (SPRMs): A Novel Therapeutic Concept in Endometriosis
CHWALISZ, K., GARG, R., BRENNER, R. M., SCHUBERT, G., & ELGER, W. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02798.x · Cited by 77
Self-citationEffects of progesterone on growth factor expression in human uterine leiomyoma
Maruo, T., Matsuo, H., Shimomura, Y., Kurachi, O., Gao, Z., Nakago, S., Yamada, T., Chen, W., & Wang, J. (2003) · Steroids · doi:10.1016/j.steroids.2003.08.017 · Cited by 77
Medical Therapy of Endometriosis
(2003) · Seminars in Reproductive Medicine · doi:10.1055/s-2003-41327 · Cited by 76
Hickey, M., Dwarte, D. M., & Fraser, I. S. (2000) · Human Reproduction · doi:10.1093/humrep/15.7.1509 · Cited by 73
Endometrial effects of long-term low-dose administration of RU486
Murphy, A. A., Kettel, L. M., Morales, A. J., Roberts, V. J., Parmley, T. H., & Yen, S. S. C. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57478-0 · Cited by 71
Bagchi, M. K., Tsai, S. Y., Tsai, M., & O’Malley, B. W. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.10.4998 · Cited by 66
5-Benzylidene-1,2-dihydrochromeno[3,4-f]quinolines as Selective Progesterone Receptor Modulators
Zhi, L., Tegley, C. M., Pio, B. A., Edwards, J. P., Motamedi, M., Jones, T. K., Marschke, K. B., Mais, D. E., Risek, B., & Schrader, W. T. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020477g · Cited by 65
Endometrial and myometrial effects of progesterone antagonists in pregnant guinea pigs
Elger, W. A. G., Fähnrich, M., Beier, S., Qing, S., & Chwalisz, K. (1987) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(87)80134-5 · Cited by 63
Self-citationChwalisz, K., Elger, W., Stickler, T., Mattia-Goldberg, C., & Larsen, L. (2005) · Human Reproduction · doi:10.1093/humrep/deh738 · Cited by 61
Self-citationHormonal contraception and chemoprevention of female cancers.
Pike, M. C., & SPICER, D. V. (2000) · Endocrine Related Cancer · doi:10.1677/erc.0.0070073 · Cited by 61
Wagner, B. L., Pollio, G., Leonhardt, S. A., Wani, M. C., Lee, D. Y., Imhof, M. O., Edwards, D., Cook, C. E., & McDonnell, D. P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8739 · Cited by 60
Non-competitive anti-oestrogenic activity of progesterone antagonists in primate models
Hodgen, G. D., van Uem, J. F. H. M., Chillik, C. F., Danforth, D. R., Wolf, J. P., Neulen, J., Williams, R. F., & Chwalisz, K. (1994) · Human Reproduction · doi:10.1093/humrep/9.suppl_1.77 · Cited by 56
Self-citationGemzell‐Danielsson, K., & Hámberg, M. (1994) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a138763 · Cited by 56
Giannoukos, G. (2001) · Molecular Endocrinology · doi:10.1210/me.15.2.255 · Cited by 55
Chwalisz, K., Fahrenholz, F., Hackenberg, M., Garfield, R. E., & Elger, W. A. G. (1991) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(91)90030-u · Cited by 53
Self-citationChwalisż, K., DeManno, D. A., Garg, R. C., Larsen, L. M., Mattia‐Goldberg, C., & Stickler, T. (2004) · Seminars in Reproductive Medicine · doi:10.1055/s-2004-828617 · Cited by 50
Self-citationAntiprogestins in the Induction of Labor
Chwalisż, K., & Garfield, R. E. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb21770.x · Cited by 50
The structure of endometrial microvessels
Hickey, M., & Fraser, I. S. (2000) · Human Reproduction · doi:10.1093/humrep/15.suppl_3.57 · Cited by 49
Mammographic breast density, hormones, and growth factors during continuous combined hormone therapy
Conner, P., Svane, G., Azavedo, E., Söderqvist, G., Carlström, K., Gräser, T., Walter, F., & von Schoultz, B. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.02.096 · Cited by 46
Chwalisz, K., Hegele‐Hartung, C., Fritzemeier, K., Beier, H. M., & Elger, W. A. G. (1991) · Endocrinology · doi:10.1210/endo-129-1-312 · Cited by 45
Self-citationScreening of anti-progestagens by receptor studies and bioassays
Kloosterboer, H. J., Deckers, G. H., van der Heuvel, M. J., & Loozen, H. J. J. (1988) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(88)90007-6 · Cited by 44
Reversible suppression of menstruation with progesterone antagonists in rhesus macaques
Slayden, O. D. (2001) · Human Reproduction · doi:10.1093/humrep/16.8.1562 · Cited by 44
ChwaliszC. Mattia-Goldberg, K., Lee, M., Elger, W., & Edmonds, A. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.07.212 · Cited by 43
Self-citationChwalisż, K., Larsen, L. M., McCrary, K., & Edmonds, A. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.07.825 · Cited by 38
Schubert, G., Elger, W. A. G., Kaufmann, G., Schneider, B., Reddersen, G., & Chwalisż, K. (2005) · Seminars in Reproductive Medicine · doi:10.1055/s-2005-864034 · Cited by 38
Self-citationWardell, S. E., & Edwards, D. P. (2005) · Seminars in Reproductive Medicine · doi:10.1055/s-2005-864030 · Cited by 36
Nonsteroidal human progesterone receptor modulators from the marine alga Cymopolia barbata.
Pathirana, C., Stein, R. B., Berger, T. S., Fenical, W., Ianiro, T. T., Mais, D. E., Torres, A., & Goldman, M. E. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08582-7 · Cited by 31
Endometrial vascular changes and bleeding disturbances with long-acting progestins
Fraserab, I. (2000) · Steroids · doi:10.1016/s0039-128x(00)00188-4 · Cited by 29
Ottow, E., Beier, S., Elger, W. A. G., Henderson, D. A., Neef, G., & Wiechert, R. (1984) · Steroids · doi:10.1016/s0039-128x(84)80033-1 · Cited by 23
Self-citationSchneider, M. R., Michna, H., Habenicht, U., Nishino, Y., Grill, H. ‐., & Pollow, K. (1992) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01410132 · Cited by 21
New 11β-aryl-substituted steroids exhibit both progestational and antiprogestational activity
Rao, P. N., Wang, Z., Cessac, J. W., Rosenberg, R. S., Jenkins, D. J. A., & Diamandis, E. P. (1998) · Steroids · doi:10.1016/s0039-128x(98)00060-9 · Cited by 20
Simbar, M., Manconi, F., Markham, R., Hickey, M., & Fraser, I. S. (2004) · Micron · doi:10.1016/j.micron.2004.01.005 · Cited by 19
Characterization of a new class of selective nonsteroidal progesterone receptor agonists
Dong, Y., Roberge, J. Y., Wang, Z., Wang, X., Tamasi, J. A., Dell, V., Golla, R., Corte, J. R., Liu, Y., Fang, T., et al. (2004) · Steroids · doi:10.1016/j.steroids.2003.12.007 · Cited by 18
Nonsteroidal progestins and antiprogestins related to flutamide
Dukes, M. (2000) · Steroids · doi:10.1016/s0039-128x(00)00179-3 · Cited by 16
Tabata, Y., Iizuka, Y., Kashiwa, J., Masuda, N. T., Shinei, R., Kurihara, K., Okonogi, T., Hoshiko, S., & Kurata, Y. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01382-6 · Cited by 14
Elger, W. A. G., Ivell, R., Nandy, A. K., Rasch, A. C., Triller, A., & Chwalisz, K. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.07.851 · Cited by 5
Self-citationElger, W. A. G., Schubert, G., Kosub, B., Matz, S., Schneider, B., & Chwalisż, K. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.07.849 · Cited by 2
Self-citation
Research works printed but not linked: 4
- Giangrande, Recent Prog Horm Res, 54, 291
- Brenner, 2005, Asoprisnil suppresses endometrial proliferation in cynomolgus macaques., J Soc Gynecol Invest, 12, 208A
- Bilyeu, 2002, Interspecies comparison: In vitro metabolism of J867 by hepatocytes and microsomes from male and female human, and various animal species., Drug Metab Rev, 34, 46
- Morris, 2002, Interspecies comparison of the metabolism of J867 following intravenous or oral administration to male and female bile duct-cannulated rats and mice., Drug Metab Rev, 34, 73
Cited by
Bulun, S. E. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804690 · Cited by 1,772
Bulun, S. E., Yilmaz, B. D., Sison, C., Miyazaki, K., Bernardi, L., Liu, S., Kohlmeier, A., Yin, P., Milad, M., & Wei, J. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00242 · Cited by 844
The Management of Uterine Leiomyomas
Vilos, G. A., Allaire, C., Laberge, P.-Y., Leyland, N., Vilos, A. G., Murji, A., & Chen, I. (2015) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(15)30338-8 · Cited by 642
Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer
Kim, J. J., Kurita, T., & Bulun, S. E. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1043 · Cited by 520
Lu, N. Z., Wardell, S. E., Burnstein, K. L., Defranco, D., Fuller, P. J., Giguere, V., Hochberg, R. B., McKay, L., Renoir, J.-M., Weigel, N. L., et al. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.4.9 · Cited by 426
Metadata
- Authors
- Chwalisz, K., Perez, M. C., DeManno, D., Winkel, C., Schubert, G., & Elger, W.
- Affiliations
- TAP Pharmaceutical Products, Inc. (K.C., M.C.P., D.D.), Lake Forest, Illinois 60045;
- Georgetown University (US)
- Jenapharm GmbH & Co. (G.S.), 07745 Jena, Germany;
- EnTec GmbH (W.E.), 07745 Jena, Germany
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2005-04-27
- Volume
- 26
- Issue
- 3
- Pages
- 423-438
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W1986914259
- Cited by
- 310
- References
- 127
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 4 · 2023: 4 · 2022: 6 · 2021: 5 · 2020: 9 · 2019: 16 · 2018: 18 · 2017: 23 · 2016: 11 · 2015: 21 · 2014: 19 · 2013: 21 · 2012: 21
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Uterine Myomas and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Keywords
- selective progesterone receptor modulators, asoprisnil, uterine fibroids, leiomyoma, endometriosis, amenorrhea, dysmenorrhea, drug development
- MeSH terms
- Animals, Clinical Trials as Topic, Endometriosis, Estrenes, Female, Humans, Leiomyoma, Oximes, Oxytocics, Progesterone, Receptors, Progesterone, Uterine Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.